Plunkett Research Online: Sonnet BioTherapeutics Holdings Inc

SONNET BIOTHERAPEUTICS HOLDINGS INC (SONN) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and.....


SONNET BIOTHERAPEUTICS HOLDINGS INC

Ticker: SONN
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 609 375-2227
Fax: 609 228-4330
Address: 100 Overlook Center
Princeton, NJ 8540 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Pankaj MohanCEO/Chairman of the Board/Director/President
John CrossCFO/Chief Accounting Officer
See More
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture